Home    eJManager.com Add Your Journal   |    Follow on Twitter   |    Subscribe to List

Directory for Medical Articles

Open Access

Original Research

Umbilical artery velocity and adverse neonatal outcome in sudanese pregnant women with severe preeclampsia

Moawia Bushra Gameraddin, Amel Alla Gabo.

Background: Doppler umbilical artery waveform is an important imaging predictor of adverse neonatal outcome in patients with severe preeclampsia. The present study aims to evaluate the adverse neonatal outcome associated with abnormal umbilical artery velocity in patients with severe preeclampsia.
Methods: In a prospective descriptive analytical hospital-based study, umbilical artery velocity and adverse fetal outcome of (104) patients with severe preeclampsia were evaluated by Doppler ultrasound. The study was conducted through the period (February to August 2015) in obstetric Sudanese population.
Results: The umbilical artery end diastolic flow was reduced in 20.2 %, absent in 5.8%, reversed in 1.9% and normal in 72.1% of the study population. The end diastolic velocity was significantly abnormal and associated with low birth weight (P-value=0.001), early neonatal death (P-value= 0.00), fetal respiratory distress (P-value = 0.00) and Apgar score (P-value = 0.00). The abnormal end diastolic flow was not statistically associated with emergency caesarean delivery (P value=0.275).
Conclusions: The end diastolic flow velocity of the umbilical artery was significantly associated with adverse neonatal and perinatal outcomes in Sudanese pregnant cases with severe preeclampsia.

Key words: Adverse, Preeclampsia, Sudanese, Umbilical artery, Velocity

Full text links

Share this Article

ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMedź Information Services.
Scopemed Buttons